logo

Tag: Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP)

Finance

ADAP’s Stock Market Pendulum: Swinging Between Gains and Losses

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -41.51%.However, over the last six months, we can see a stronger performance of -69.99%. Over